CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 22  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0732
LYS 10.0295
GLU 20.0732
LEU 30.0126
ARG 40.0268
CYS 50.0232
GLN 60.0142
CYS 70.0128
ILE 80.0142
LYS 90.0132
THR 100.0105
TYR 110.0139
SER 120.0149
LYS 130.0260
PRO 140.0194
PHE 150.0083
HIS 160.0178
PRO 170.0179
LYS 180.0202
PHE 190.0150
ILE 200.0122
LYS 210.0161
GLU 220.0166
LEU 230.0095
ARG 240.0062
VAL 250.0057
ILE 260.0105
GLU 270.0142
SER 280.0119
GLY 290.0083
PRO 300.0570
HIS 310.0221
CYS 320.0135
ALA 330.0141
ASN 340.0170
THR 350.0117
GLU 360.0103
ILE 370.0058
ILE 380.0057
VAL 390.0069
LYS 400.0083
LEU 410.0027
SER 420.0090
ASP 430.0173
GLY 440.0176
ARG 450.0249
GLU 460.0142
LEU 470.0043
CYS 480.0065
LEU 490.0069
ASP 500.0089
PRO 510.0055
LYS 520.0067
GLU 530.0033
ASN 540.0047
TRP 550.0082
VAL 560.0069
GLN 570.0089
ARG 580.0137
VAL 590.0157
VAL 600.0148
GLU 610.0183
LYS 620.0169
PHE 630.0179
LEU 640.0152
LYS 650.0134
ARG 660.0074
ALA 670.0121
GLU 680.0403
ASN 690.0569

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.